21
© WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm Quality Assurance and Safety: Medicines, Medicines Policy and Standards, Health Technology and Pharmaceuticals Cluster Tel: +41.22.791.3598 Fax: +41.22.791.4730 World Health Organization E-mail: [email protected] Supplementary Training Modules on Good Manufacturing Practices

© WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

Embed Size (px)

Citation preview

Page 1: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validations –part 5

Workshop onGMP and Quality Assurance of TB products

Kuala LumpurMalaysia, 21 – 25 February 2005

Maija Hietava M.Sci.Pharm

Quality Assurance and Safety: Medicines, Medicines Policy and Standards, Health Technology and Pharmaceuticals Cluster

Tel: +41.22.791.3598 Fax: +41.22.791.4730World Health Organization

E-mail: [email protected]

Supplementary Training Modules on Good Manufacturing Practices

Page 2: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Analytical validation

Introduction

Why is analytical monitoring necessary?

What is the purpose of analytical validation?

Page 3: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validation

Objectives

To introduce the concepts of : Protocol development

Instrument qualification

Analytical procedure

Extent of validation

Method transfer

Page 4: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validation of analytical procedures requires: Qualified and calibrated instruments

Documented methods

Reliable reference standards

Qualified analysts

Sample integrity

Validation

Page 5: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validation protocol for analytical method Statement of purpose and scope Responsibilities Documented test method List of materials and equipment Procedure for the experiments for each parameter Statistical analysis Acceptance criteria for each performance parameter

Validation

Page 6: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Qualification of the instrument

Supplier, model and supplier´s manual

Modifications

Installation and operational qualification

Calibration programs

Maintenance schedules

Validation

Page 7: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Characteristics of analytical procedures (1) Accuracy

Precision

Repeatability

Reproducibility

Validation

Page 8: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Inaccurate &imprecise

Inaccurate butprecise

Accurate butimprecise

Validation

Relationship between accuracy and precision

Accurate AND Precise

Page 9: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Characteristics of analytical procedures (2)

Ruggedness Robustness Variability caused by:

Day-to-day variations Analyst-to-analyst Laboratory-to-laboratory Instrument-to-instrument Chromatographic column-to-column Reagent kit-to-kit Instability of analytical reagents

Validation

Page 10: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Characteristics of analytical procedures (3)

Linearity and range

Specificity

Sensitivity

Limit of detection

Limit of quantitation

Validation

Page 11: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

LOQ, LOD and SNR

Limit of Quantitation

Limit of Detection

Signal to Noise Ratio

noise

Peak ALOD

Peak BLOQ

Baseline

Validation

Page 12: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Different classes of analytical tests

Class A: To establish identity

Class B: To detect and quantitate impurities

Class C: To determine quantitatively the concentration

Class D: To assess the characteristics

Validation

Page 13: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

  

* A degree of bias may be allowed

Characteristic A B quant.

B Limit test

C D

Accuracy 

  X   X X*

Precision   X   X X

Robustness X X X X X

Linearity and range

  X   X X

Specificity X X X X X

Limit of detection   X    

Limit of quantitation

  X      

Validation

Page 14: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Extent of validation

New methods require complete validation

Pharmacopoeial methods require partial validation (or verification)

Significant changes mean partial revalidation equipment changes formula changed changed suppliers of critical reagents

Validation

Page 15: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Analytical method transfer Method transfer protocol and procedure

precision accuracy ruggedness

Written and approved specific test method

Proficiency check

Formal acceptance by new laboratory

Validation

Page 16: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validation

Typical validation of HPCL assay (1)

System suitability (performance check) system precision column efficiency symmetry factor capacity factor

Page 17: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Validation

Typical validation of HPLC assay (2) Method validation

specificity accuracy precision linearity robustness

Page 18: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Biological assays Can be difficult to "validate"

"Validity" on a case by case basis

Strictly adhere to the Biological Testing monographs in pharmacopoeias

Validation

Page 19: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Microbiological testing requiring validation

Microbial limit testing

Microbial count

Sterility testing

Preservative effectiveness testing

Environmental monitoring program

Biological testing

Validation

Page 20: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Sterility testing validation

requirements

Media growth promotion, sterility, pH

Product validation

Stasis testing

Environmental monitoring

Negative controls

Challenge organisms

Validation

Page 21: © WHO – PSM Validations –part 5 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm

© WHO – PSM

Question no 34

What is the validation parameter showing that results of analysis are almost all in line??

Validation